Share this article
Share this article
ResearchAndMarkets.com's offering.
The global genetic counseling market was valued at $972.2 million in 2019 and is anticipated to grow over $4,079.3 million by 2030.
The pharmacogenomic genetic counseling segment is expected to witness a robust CAGR of 17.39% during the forecast period, 2020-2030.
GeneDX and InformedDNA are currently the largest shareholders in the global genetic counseling market. This market dominance is attributed to the company's presence within the market through its expansive service portfolio, led by dedicated genetic counselors' workforce that provides services in prenatal/preconception, pediatric, indication risk assessment, and pharmacogenomic counseling and other genetic counseling services.